SOAT1 and obesity disorder: The JAK-STAT signaling pathway plays a pivotal role not only in immune and inflammatory regulation, but is also closely associated with a variety of metabolic disorders, including obesity, insulin resistance, non-alcoholic fatty liver disease, and atherosclerosis [42,43].